top of page

A clinical trial of transcranial magnetic stimulation (TMS) in autism spectrum disorder

TMS is a form of non-invasive brain stimulation. It is administered through a plastic-coated metallic coil that generates brief but powerful magnetic pulses. When these pulses are delivered to the scalp, they create a small amount of electricity in the brain that stimulates nerve cells.

​

Participants in this study will undergo 20 sessions of TMS. In this study, we apply TMS to a region of the brain called the right temporoparietal junction, or rTPJ. The rTPJ is a part of the brain that is involved in social understanding and social communication.

​

Some participants will receive the real form of TMS, while others will receive a sham or placebo form. The sham or placebo form mimics the feeling of TMS, but no brain stimulation is delivered.

​

Find out more on the study website.

Recruitment

To be eligible for this study, participants must be:

  • Aged 14 - 40 years old

  • Have a formal autism diagnosis

  • Be fluent/proficient in English

Not have any medical condition listed in the exclusion criteria

​

This study is currently OPEN. Register your interest below. 

Contact CAN Research

Brain and Mind Centre

University of Sydney

94 Mallet Street

Camperdown, NSW, 2050

Tel: 02 9114 4104

Final_CAN_logo_2022 (1).png

The Children’s Hospital at Westmead

Cnr Hawkesbury Road & Hainsworth Street

Westmead, NSW, 2145

​

We use identity-first language (autistic person)  rather than person-first language (person with autism) throughout the site.
Find out more about our decision to do so. 

 

Privacy Policy

bottom of page